TLSITriSalus Life Sciences Inc
TLSI
TriSalus Life Sciences Inc333
Mkt Cap
$211.89MVolume
278,214.0052W High
$7.9552W Low
$2.20PE Ratio
-2.45TLSI Fundamentals
Price
$3.28Prev Close
$3.45Open
$3.4650D MA
$4.08Beta
0.48Avg. Volume
135,317.50EPS (Annual)
-$1.84P/B
16.54Rev/Employee
$442,656.86$278.53
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of TriSalus Life Sciences Inc. (TriSalus or the Company) (NASDAQ: TLSI) investors concerning the Companys possible violations of the federal securities...
TriSalus Life Sciences Inc. (TLSI) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of TriSalus Life Sciences Inc. (TriSalus or the Company) (NASDAQ: TLSI) investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN TRISALUS LIFE SCIENCES INC...
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud
Shareholders who held TriSalus Life Sciences Inc. (TLSI) stock lost money after the company cut its full-year 2026 revenue guidance to $54 million-$57 million, down from the $60 million-$62 million...
Securities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of TriSalus Life Sciences Inc. (TriSalus or the Company) (NASDAQ: TLSI) on behalf of investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON TRISALUS LIFE SCIENCES INC...
TriSalus Life Sciences Q1 2026 Earnings Call: Complete Transcript
read more...
TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates
TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of +12.50% and -15.25%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
TriSalus Life Sciences Reports First Quarter 2026 Results Demonstrating Commercial and Clinical Progress for Facilitating Long-Term Growth
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the Company), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announced financial results for the quarter...
Real-World PEDD Study Published in the Journal of Comparative Effectiveness Research Shows Improved Clinical Outcomes and Meaningful Charge Avoidance
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the Company), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to transform treatment for patients with solid tumors, today announced the publication of the largest...
VAREX IMAGING (VREX) Q2 Earnings and Revenues Miss Estimates
VAREX IMAGING (VREX) delivered earnings and revenue surprises of -4.55% and -0.55%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
TriSalus Life Sciences (TLSI) Projected to Post Quarterly Earnings on Tuesday
TriSalus Life Sciences (NASDAQ:TLSI) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at...
<
1
2
...
>
Compact View
Not available
Not available
Advertisement|Remove ads.
Latest TLSI News
ViewSecurities Fraud Investigation Into TriSalus Life Sciences Inc. (TLSI) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
TriSalus Life Sciences Inc. (TLSI) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
TLSI Investor Alert: Levi & Korsinsky Investigates TLSI (TLSI) for Potential Securities Fraud
Advertisement|Remove ads.